Fentanyl Citrate

CAS 990-73-8 15 current records 6 historicalSmall Molecule

Who holds supplier records for Fentanyl Citrate? 15 organisations hold a current record for Fentanyl Citrate: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: United States (3), United Kingdom (1), Germany (1), South Africa (1) and 6 other countries (6); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Fentanyl Citrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fentanyl-citrate

Reading the evidence

  • 15 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (15)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Fentanyl Citrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Fentanyl Citrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (13)

Certificates of Suitability on the EDQM register for Fentanyl Citrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
Grindeks AS RigaLV
CEP 2024-274 - Rev 00
Fentanyl citrate
May 2026Inspected Mar 2026
Latvia
VERANOVA, L.P. West DeptfordUS
CEP 2005-104 - Rev 05
Fentanyl citrate
Dec 2025—
SIEGFRIED GRAFTON INC. GraftonUS
CEP 2005-081 - Rev 04
Fentanyl citrate
Jul 2025—
SANECA PHARMACEUTICALS A.S. HlohovecSK
CEP 2009-230 - Rev 01
Fentanyl citrate
Nov 2024Inspected Jun 2026
Slovakia
AREVIPHARMA GMBH RadebeulDE
CEP 2007-340 - Rev 02
Fentanyl citrate
Apr 2024Inspected Jun 2025
Germany
SPECGX LLC Webster GrovesUS
CEP 2009-097 - Rev 02
Fentanyl citrate
Jan 2024—
YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. YichangCN
CEP 2007-208 - Rev 03
Fentanyl citrate
Nov 2023Inspected Jul 2026
Hungary
Rusan Pharma Ltd. MumbaiIN
R1-CEP 2016-023 - Rev 00
Fentanyl citrate
May 2022—
CAMBREX CHARLES CITY, INC. Charles CityUS
R1-CEP 2006-288 - Rev 01
Fentanyl citrate
Sept 2019—
FINE CHEMICALS CORPORATION (PTY) LTD. Cape TownZA
R1-CEP 2013-071 - Rev 00
Fentanyl citrate
Sept 2019—
JANSSEN PHARMACEUTICA NV BeerseBE
R1-CEP 1998-045 - Rev 06
Fentanyl citrate
Jun 2019—
MACFARLAN SMITH LIMITED EdinburghGB
R1-CEP 2000-303 - Rev 04
Fentanyl citrate
Oct 2014—
Kern Pharma, S.L. TerrassaES
R1-CEP 2005-068 - Rev 01
Fentanyl citrate
Jan 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Fentanyl Citrate are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • United States · Inactive DMF 19081 · filed Jan 2006
  • BOEHRINGER INGELHEIM CHEMICALS INC
    Inactive DMF 17826 · filed Nov 2004
  • Inactive DMF 8513 · filed Apr 1990
  • ABBOTT PHARMACEUTICALS INC
    Inactive DMF 8279 · filed Nov 1989
  • MALLINCKRODT CHEMICAL INC
    Inactive DMF 7051 · filed Jul 1987
  • DIOSYNTH BV
    Inactive DMF 4751 · filed Jan 1983

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Fentanyl citrate is a potent synthetic opioid analgesic used for the treatment of severe pain and as an anesthetic adjunct. It is highly effective for pain relief, but carries risks of addiction and respiratory depression.

Chemical identity

IUPAC name
2-hydroxypropane-1,2,3-tricarboxylic acid;N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Canonical SMILES
CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChIKey
IVLVTNPOHDFFCJ-UHFFFAOYSA-N
Synonyms
Duragesic API, abstral, actiq, effentora, fentanyl buccal, fentanyl citrate cii, fentora, innovar component fentanyl citrate, instanyl, kw-2246, lazanda, leptanal

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Opioid Agonist
Mechanism of action
Full Opioid Agonists

Therapeutic areas

Pain ManagementAnesthesiaPalliative Care

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Fentanyl Citrate?

15 organisations hold an active US FDA Type II Drug Master File or a CEP for Fentanyl Citrate: CAMBREX CHARLES CITY INC (United States), SPECGX LLC (United States), CHATTEM CHEMICALS INC (United States), CURIA WISCONSIN INC, VERANOVA LP (United Kingdom), Arevipharma GmbH (Germany), Fine Chemicals Corporation (PTY) Ltd. (South Africa) and Grindeks (Latvia), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Fentanyl Citrate Drug Master Files are active?

CAMBREX CHARLES CITY INC (DMF 19724, 17055), SPECGX LLC (DMF 10128), CHATTEM CHEMICALS INC (DMF 23013), CURIA WISCONSIN INC (DMF 18178) and VERANOVA LP (DMF 5038). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Fentanyl Citrate records mean?

6 organisations have only inactive Type II DMFs for Fentanyl Citrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Fentanyl Citrate have a European Certificate of Suitability?

Yes. 13 organisations hold a valid CEP for Fentanyl Citrate on the EDQM register, including Grindeks AS Riga (LV), VERANOVA, L.P. West Deptford (US), SIEGFRIED GRAFTON INC. Grafton (US), SANECA PHARMACEUTICALS A.S. Hlohovec (SK), AREVIPHARMA GMBH Radebeul (DE) and SPECGX LLC Webster Groves (US) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Fentanyl Citrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Fentanyl Citrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.